Updates in Community Oncology 2009: Optimizing Patient Outcomes in Ovarian and Cervical Cancer

• Stacy J. Rogers, MD
  Deborah Armstrong, MD

Updates in Community Oncology 2009: Improving Therapeutic Strategies for the Management of Renal Cell Carcinoma

• Mark T. Fleming, MD
  Daniel George, MD

Updates in Community Oncology: Current Strategies to Optimize Treatment and Improve Patient Outcomes for Non-small Cell Lung Cancer

• Robert Jotte, MD, PhD
  Dennis L. Carter, MD
  Ramaswamy Govindan, MD
  

UPDATES IN COMMUNITY ONCOLOGY: A Focus on Multiple Myeloma and Myelodysplastic Syndromes e-monograph

• John M. Burke, MD
  Henry C. Fung, MD, FRCPE

UPDATES IN COMMUNITY ONCOLOGY: Improving Therapeutic Strategies for the Management of Early and Metastatic Breast Cancer e-monograph

• Thomas H. Cartwright, MD
  Ruby Kochhar, MD

UPDATES IN COMMUNITY ONCOLOGY: Data From Orlando 2009: Personalizing Treatment of Head and Neck Cancer, Hematologic Malignancies, and Gastrointestinal Cancers e-monograph

• Thomas P. Flynn, MD
  John F. Deeken, MD
  Gautam Borthakur, MD
  Patrick J. Flynn, MD
  

Healthcare Provider Conference 2008:
Collaboration for Advancing the Quality of Community
Cancer Care

• Module I: New Drugs & Indications: Focus on Hematologic Disorders and Solid Tumors (Module review time- 34:29)
  Jill Kolesar, PharmD, BCPS, FCCP, RPh
  Modules I through V must all be taken to receive credit.
• Module II: Reimbursement in the Oncology Practice: 2008 Update and Audience Case Challenges (Module review time- 33:10)
  Karen Pilley, CPC, CCS-P
  Modules I through V must all be taken to receive credit.
• Module III: Breast Cancer: Implementing Advances into Practice (Module review time- 38:26)
  Mary Ann K. Allison, MD, FACP
  Modules I through V must all be taken to receive credit.
• Module IV: Bone Marrow Transplantation: The Basics (Module review time- 35:22)
  Roy A. Beveridge, MD
  Modules I through V must all be taken to receive credit.
• Module V: Integrative Medicine and Community Cancer Care: Putting it into Practice (Module review time- 24:49)
  Sami Diab, MD Joan Engebretson, DrPH, AHN-BC, RN Michael Forsyth, RPh, MBA Moshe Frenkel, MD Patty Gerken, ANP-BC, AOCN
  Modules I through V must all be taken to receive credit.

Treatment-Related Highlights from Chicago 2008
August 2008

Session I

• Module I: Hematologic Malignancy Updates
  Nicholas DiBella, MD
• Module II: Updates in Genitourinary Cancers
  William Berry, MD

Session II

• Module III: Lung Cancer Updates
  Robert Jotte, MD, PhD
• Module IV: Updates on Gastrointestinal Cancer
  Thomas H. Cartwright, MD

Session III

• Module V: Breast Cancer Updates
  Michael Kolodziej, MD
• Module VI: Biomarkers and Individualization of Treatment in Cancer Patients
  Howard L. McLeod, PharmD

Infections in Cancer Patients:
Prevention and Management in the Community Care Setting
April 2008

• Session I: Practical Management of Febrile Neutropenia
  Amar Safdar, MD, Estil Vance, MD
• Session II: Emerging Bacterial/MRSA Infections
  Roy F. Chemaly, MD, MPH, FACP, FIDSA, Estil Vance, MD
• Session III: Practical Management & Prevention of Infections in Cancer Patients
  Amar Safdar, MD, Estil Vance, MD

The Role of Systemic Chemotherapy in Prostate Cancer:
Maximizing Clinical Outcomes
March 2008

• Module I: The Role of Systemic Chemotherapy in Prostate Cancer: Maximizing Clinical Outcomes
  Matthew D. Galsky, MD, Thomas E. Hutson, DO, PharmD

Practice-Changing Highlights from Chicago 2007
July 2007

• Module I: Breast Cancer Adjuvant/Neoadjuvant Therapy
• Module II: Genitourinary Cancers
• Module III: Supportive Care and Other Advances
• Module IV: Advances in Treatment of Hematologic Malignancies
• Module V: Gastrointestinal Cancers
• Module VI: Lung Cancer

Advancing Today’s Knowledge on Gaucher Disease
June 2007

• Module: Advancing Today’s Knowledge on Gaucher Disease

Oncology Nursing, Midlevel Practitioner and Pharmacy Conference 2006: Collaboration for Advancing the Quality of Community Cancer Care
December 2006

• Module I: Novel Therapies in the Treatment of Multiple Myeloma, Lymphoma and Myelodysplastic Syndromes
• Module II: From the Bench to the Bedside: New Drug Highlights
• Module III: At the Crossroads: End of Life Issues in
  Cancer Care
• Module IV: Facilitating Communication on Sensitive Issues in Cancer Care
• Module V: On the Horizon of Genetic Research: From Investigator to Reporter to the Public
• Module VI: Women and Cancer: A Focus on Cervical and Ovarian Cancers
• Module VII: Breast Cancer: Application of the Latest Data and Its Implications
• Module VIII: Cancer Comorbidities: Understanding and Managing Toxicity Risks and Late Effects of Treatment
• Module IX: Supportive Care Therapies and Management
• Module X: Optimizing Oral Therapies: What We Need to Know About Delivery and Compliance
• Module XI: Delivering Cancer Care in 2006: Commanding Reimbursement and Regulatory Issues